VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017 09 06; 25(9):2214-2224.
View in:
PubMed
subject areas
Adolescent
Antineoplastic Agents, Immunological
Child
Child, Preschool
Cohort Studies
Combined Modality Therapy
Cytokines
Female
Humans
Immunotherapy, Adoptive
Lymphocyte Count
Lymphocyte Depletion
Male
Molecular Targeted Therapy
Myeloid Cells
Neuroblastoma
Programmed Cell Death 1 Receptor
Receptors, Antigen, T-Cell
Recombinant Fusion Proteins
T-Lymphocytes
Transplantation Conditioning
Treatment Outcome
Young Adult
authors with profiles
NADIA MAHMOOD
BAMBI GRILLEY
MALCOLM BRENNER
HELEN HESLOP
CLIONA ROONEY
ZHUYONG MEI
ADRIAN GEE
ANDRAS HECZEY